Keywords: آپولیپوپروتئین A-II; 8-OHdG; 8-hydroxy-2â²-deoxyguanosine; AIC; Akaike Information Criterion; α-2-M; alpha-2-macroglobulin; Apo-AI; apolipoprotein A-I; Apo-AII; apolipoprotein A-II; CRP; C-reactive protein; CNF; carbon nanofibers; CNT; carbon nanotubes; CNT/F; carbon nanotu
مقالات ISI آپولیپوپروتئین A-II (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Study of the relationship between APOA-IIÂ â265T>C polymorphism and HDL function in response to weight loss in overweight and obese type 2 diabetic patients
Keywords: آپولیپوپروتئین A-II; Apolipoprotein A-II; Polymorphism; Obesity; Diabetes; Paraoxonase; Pentraxin-3;
Insulin resistance involvement in prevalence of familial dysbetalipoproteinemia in ε2ε2 subjects by Bayesian network modeling
Keywords: آپولیپوپروتئین A-II; apoA-I; apolipoprotein A-I; apoA-II; apolipoprotein A-II; apoE; apolipoprotein E; apoB; apolipoprotein B; BN; Bayesian network; FD; familial dysbetalipoproteinemia; HDL-C; high-density lipoprotein cholesterol; HOMA-IR; Homeostatic Model Assessment of Insu
Anti-obesity effect of radix Angelica sinensis and candidate causative genes in transcriptome analyses of adipose tissues in high-fat diet-induced mice
Keywords: آپولیپوپروتئین A-II; RAS; Radix Angelica sinensis; HFD; high-fat diet; DEGs; differentially-expressed genes; qPCR; quantitative real-time PCR; TCMs; Chinese herbal medicines; RIN; RNA integrity number; FPKM; fragments per kilobase of transcript per million fragments mapped; F
Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3c
Keywords: آپولیپوپروتئین A-II; ANOVA; analysis of variance; ApoAI; apolipoprotein A-I; ApoA-II; apolipoprotein A-II;; ApoB; apolipoprotein B; BMI; Body Mass Index; CVD; cardiovascular disease; CE; cholesteryl ester; Cer; ceramide; CETP; cholesteryl ester transfer protein; EDTA; ethylen
Posttranslational modifications of apolipoprotein A-II proteoforms in type 2 diabetes
Keywords: آپولیپوپروتئین A-II; Apolipoprotein A-II; Oxidations; Mass spectrometry; Diabetes;
Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism in individuals with prediabetes: A randomized controlled trial
Keywords: آپولیپوپروتئین A-II; Clinical trial; Glucose metabolism; Type 2 diabetes; High-density lipoprotein; Prediabetes; ALT; alanine aminotransferase; AMPK; AMP-activated protein kinase; ApoA-I; apolipoprotein A-I; ApoA-II; apolipoprotein A-II; AST; aspartate aminotransferase; BET;
Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans
Keywords: آپولیپوپروتئین A-II; Apolipoprotein A-II; Lipid metabolism; VLDL; Triglyceride rich lipoproteins; TRL; triglyceride rich lipoproteins; VLDL; very low density lipoproteins; apoB; apolipoprotein B; apoA-II; apolipoprotein A-II; LPL; lipoprotein lipase; FCR; fractional catabolic
Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics
Keywords: آپولیپوپروتئین A-II; [15N]APOA1; 15N-labeled apolipoprotein A-I; APOA1; apolipoprotein A-I; APOA2; apolipoprotein A-II; CVD; cardiovascular disease; HCD; high-energy collisional dissociation; HDL; high density lipoprotein; LLOQ; lower limit of quantification; MRM; multiple re
Análisis del proteoma hepático de ratones transgénicos de apo A-II humana: identificación de proteÃnas potencialmente implicadas en la regulación del metabolismo de triglicéridos y la respuesta a la insulina
Keywords: آپولیپوپروتئین A-II; ApolipoproteÃna A-II; Arteriosclerosis; LipoproteÃnas de alta densidad; LipoproteÃnas de muy baja densidad; Proteómica; Ratones transgénicos; Apolipoprotein A-II; Atherosclerosis; High density lipoproteins; Very low density lipoprotein; Proteomics; T
Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate
Keywords: آپولیپوپروتئین A-II; Apolipoprotein A-II; Familial combined hyperlipidemia; Fibrate; Peroxisome-proliferator-activated receptor α; Very-low-density lipoprotein;
NDRG1 interacts with APO A-I and A-II and is a functional candidate for the HDL-C QTL on 8q24
Keywords: آپولیپوپروتئین A-II; NDRG1; High density lipoprotein; Apolipoprotein A-I; Apolipoprotein A-II; Charcot-Marie-Tooth disease; Neuropathy; CMT4D;